Proper Dosage of Ketamine in Intravenous Regional Anesthesia

Pain. Clinical Trial

Official title: Proper Dosage of Intravenous Ketamine When Used as an Adjuvant to Lidocaine in Intravenous Regional Anesthesia (IVRA).

Status Recruiting

Clinical Trial Summary

Ketamine added to Lidocaine can increase duration of pain relief following intraveonous regional anesthesia (IVRA). The purpose of this dose response study is to determine the minimum effective dosage of intravenous Ketamine, added to 3 mg/kg of Lidocaine. We anticipate that one dosage will provide us with the proper balance between sufficient anesthesia and minimal side effects.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Pain.

• NCT number: NCT00221871
• Study type: Interventional
• Source: University Health Network, Toronto
• Contact: Colin McCartney, MD
• Phone: (416)603-5118
• Email: colin.mccartney@uhn.on.ca
• Status: Recruiting
• Phase: N/A
• Start date: January 2004
• Completion date: January 2005